Calcification of Cardiac Valves in Metabolic Bone Disease: An Updated Review of Clinical Studies

References

• Barasch E, Gottdiener JS, Marino Larsen EK, Chaves PH, Newman AB. Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). Am Cardiol. 2006;97(9):1281–1286. doi:10.1016/j.amjcard.2005.11.065
   PubMed Web of Science ®Google Scholar
• Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis. Nature Rev Dis Primers. 2016;3(2):16006. doi:10.1038/nrdp.2016.6
   Web of Science ®Google Scholar
• Shekar C, Budoff M. Calcification of the heart: mechanisms and therapeutic avenues. Expert Rev Cardiovasc Ther. 2018;16(7):527–536. doi:10.1080/14779072.2018.148428229860888
   PubMed Web of Science ®Google Scholar
• Chester AH. Molecular and cellular mechanisms of valve calcification. Aswan Heart Centre Sci Pract Series. 2011;4. doi:10.5339/ahcsps.2011.4
   Google Scholar
• Gomel MA, Lee R, Grande-Allen KJ. Comparing the role of mechanical forces in vascular and valvular calcification progression. Front Cardiovasc Med. 2019;197(5):1–14.
   Google Scholar
• Sud K, Agarwal S, Parashar A, et al. Degenerative mitral stenosis: unmet need for percutaneous interventions. Circulation. 2016;133(16):1594–1604. doi:10.1161/CIRCULATIONAHA.115.02018527142604
   PubMed Web of Science ®Google Scholar
• Pawade TA, Newby DE, Dweck MR. Calcification in aortic stenosis: the skeleton key. J Am CollCardiol. 2015;66(5):561–577. doi:10.1016/j.jacc.2015.05.066
   Web of Science ®Google Scholar
• Kennedy JA, Hua X, Mishra K, Murphy GA, Rosenkranz AC, Horowitz JD. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors. Eur J Pharmacol. 2009;602:28–35. doi:10.1016/j.ejphar.2008.11.02919056377
   PubMed Web of Science ®Google Scholar
• Clark-Greuel JN, Connolly JM, Sorichillo E, et al. Transforming growth Factor-β1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg. 2007;83:946–953. doi:10.1016/j.athoracsur.2006.10.02617307438
   PubMed Web of Science ®Google Scholar
• Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res. 2004;95:253–260. doi:10.1161/01.RES.0000136520.07995.aa15217906
   PubMed Web of Science ®Google Scholar
• Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation. 2001;103:1522–1528. doi:10.1161/01.CIR.103.11.152211257079
   PubMed Web of Science ®Google Scholar
• Hjortnaes J, Butcher J, Figueiredo JL, et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J. 2010;31(16):1975–1984. doi:10.1093/eurheartj/ehq23720601388
   PubMed Web of Science ®Google Scholar
• Chiyoya M, Seya K, Yu Z, et al. Matrix Gla protein negatively regulates calcification of human aortic valve interstitial cells isolated from calcified aortic valves. J PharmacolSci. 2018;136(4):257–265.
   Google Scholar
• Di Minno A, Zanobini M, Myasoedova VA, et al. Could circulating fetuin A be a biomarker of aortic valve stenosis? Int J Cardiol. 2017;249:426–430. doi:10.1016/j.ijcard.2017.05.04028931474
   PubMed Web of Science ®Google Scholar
• Carracedo M, Back M. Fetuin A in aortic stenosis and valve calcification: not crystal clear. Int J Cardiol. 2018;265(15):77–78. doi:10.1016/j.ijcard.2018.04.11529885702
   PubMed Web of Science ®Google Scholar
• Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation. 2005;112:1229–1234.
   Web of Science ®Google Scholar
• Bortnik AE, Xu S, Kim RS, et al. Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2019;285:79–86. doi:10.1016/j.atherosclerosis.2019.04.21531048102
   PubMed Web of Science ®Google Scholar
• Iwata S, Hyodo E, Yanagi S, et al. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol. 2013;163(3):256–259. doi:10.1016/j.ijcard.2011.06.02521705098
   PubMed Web of Science ®Google Scholar
• Iwata S, Walker MD, Di Tullio MR, et al. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2012;97(1):132–137. doi:10.1210/jc.2011-210722031523
   PubMed Web of Science ®Google Scholar
• Osman L, Chester AH, Amrani M, Yacoub MH, Smolenski RT. A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. Circulation. 2006;114:I566–I572. doi:10.1161/CIRCULATIONAHA.105.00121416820639
   PubMed Web of Science ®Google Scholar
• Mori H, Oku Y, Hashiba K, Seto M, Mameya G. The relationship of osteoporosis to mitral annular and aortic valvular calcification in elderly women. J Cardiography. 1990;20(2):393–399.
   Google Scholar
• Ouchy Y, Akishita M, de Souza AC, Nakamura T, Orimo H. Age-related loss of bone mass and aortic/aortic valve calcification—re evaluation of recommended dietary allowance of calcium in the elderly. Ann N Y Acad Sci. 1993;676:297–307. doi:10.1111/j.1749-6632.1993.tb38743.x8489141
   PubMed Web of Science ®Google Scholar
• Sugihara N, Matsuzaki M. The influence of severe bone loss on mitral annular calcification in postmenopausal osteoporosis of elderly Japanese women. Jpn Circ J. 1993;57(1):14–26. doi:10.1253/jcj.57.148437338
   PubMedGoogle Scholar
• Davutoglu V, Yilmaz M, Soydinc S, et al. Mitral annular calcification is associated with osteoporosis in women. Am Heart J. 2004;147:1113–1116. doi:10.1016/j.ahj.2003.12.00215199364
   PubMed Web of Science ®Google Scholar
• Aksoy Y, Yagmur C, Tekin GO, et al. Aortic valve calcification: association with bone mineral density and cardiovascular risk factors. Coron Artery Dis. 2005;16:379–383. doi:10.1097/00019501-200509000-0000716118543
   PubMed Web of Science ®Google Scholar
• Pfister R, Michels G, Sharp SJ, Luben R, Wareham NJ, Khaw KT. Inverse association between bone mineral density and risk of aortic stenosis in men and women in EPIC-Norfolk prospective study. Int J Cardiol. 2015;178:29–30. doi:10.1016/j.ijcard.2014.10.06525464212
   PubMed Web of Science ®Google Scholar
• Choi HS, Rhee Y, Hur NW, Chung N, Lee EJ, Lim SK. Association between low bone mass and aortic valve sclerosis in Koreans. Clin Endocrinol. 2009;71:792–797. doi:10.1111/j.1365-2265.2009.03543.x
   Web of Science ®Google Scholar
• Tohiono S, Tohno Y, Minami T, et al. Accumulation of calcium and phosphorus in the mitral valve in comparison with the abdominal aorta and the scaphoid bone. Biol Trace Elem Res. 2000;77:33–42. doi:10.1385/BTER:77:1:3311097469
   PubMed Web of Science ®Google Scholar
• Celick A, Davutoglu V, Sarica K, et al. Relationship between renal stone formation, mitral annular calcification and bone resorption markers. Ann Saudi Med. 2010;30(4):301–305. doi:10.4103/0256-4947.6526420622348
   PubMed Web of Science ®Google Scholar
• Hasserius R, Karlsson MK, Nilsson BE, Redlund-Johnell I, Johnell O. European vertebral osteoporosis study.Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European vertebral osteoporosis study. Osteoporos Int. 2003;14(1):61–68. doi:10.1007/s00198-002-1316-912577186
   PubMed Web of Science ®Google Scholar
• Bandeira E, Neves AP, Costa C, Bandeira F. Association between vascular calcification and osteoporosis in men with type 2 diabetes. J Clin Densitom. 2012;15(1):55–60. doi:10.1016/j.jocd.2011.07.00222071025
   PubMed Web of Science ®Google Scholar
• Silva HC, Pinheiro MM, Genaro PS, et al. Higher prevalence of morphometric vertebral fractures in patients with recent coronary events independently of BMD measurements. Bone. 2013;52(2):562–567. doi:10.1016/j.bone.2012.11.00423142805
   PubMed Web of Science ®Google Scholar
• Buckens CF, de Jong PA, Verkooijen HM, Verhaar HJ, Mali WP, van der Graaf Y. PROVIDI study group. Vertebral fractures on routine chest computed tomography: relation with arterial calcifications and future cardiovascular events. Int J Cardiovasc Imaging. 2015;31(2):437–445. doi:10.1007/s10554-014-0567-925451815
   PubMed Web of Science ®Google Scholar
• Schulz EJ, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004;89(9):4246–4253. doi:10.1210/jc.2003-03096415356016
   PubMed Web of Science ®Google Scholar
• Szulc P, Kiel DP, Delmas PD. Calcifications in the abdominal aorta predict fractures in men: MINOS study. J Bone Miner Res. 2008;23(1):95–102. doi:10.1359/jbmr.07090317892380
   PubMed Web of Science ®Google Scholar
• Gondrie MJ, Mali WP, Buckens CF, Jacobs PC, Grobbee DE, van derGraaf Y. The PROgnostic value of unrequested information in diagnostic imaging (PROVIDI) study: rationale and design. Eur J Epidemiol. 2010;25(10):751–758. doi:10.1007/s10654-010-9514-920890635
   PubMed Web of Science ®Google Scholar
• Chan JJ, Cupples LA, Kiel D, O’Donnell CJ, Hoffmann U, Samelson EJ. QCT volumetric bone mineral density and vascular and valvular calcification: the framingham study. J Bone Miner Res. 2015;30(10):1767–1774. doi:10.1002/jbmr.253025871790
   PubMed Web of Science ®Google Scholar
• Messera D, Xu S, Bartz TM, et al. Relationship of bone mineral density with valvular and annular calcification in community-dwelling older people: the cardiovascular health study. Arch Osteoporos. 2017;12(1):52. doi:10.1007/s11657-017-0347-y28560501
   PubMed Web of Science ®Google Scholar
• Roberts WC, Waller BF. Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med. 1981;71(3):371–384. doi:10.1016/0002-9343(81)90163-77282728
   PubMed Web of Science ®Google Scholar
• Nierdle B, Stefenelli T, Glogar D, Woloszczuk W, Roka R, Mayr H. Cardiac calcific deposits in patients with primary hyperparathyroidism: preliminary results of a prospective echocardiographic study. Surgery. 1990;108(6):1052–1056.2247830
   PubMed Web of Science ®Google Scholar
• Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B. Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med. 1993;95(2):197–202. doi:10.1016/0002-9343(93)90260-V8356983
   PubMed Web of Science ®Google Scholar
• Stefenelli T, Abela C, Frank H, et al. Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab. 1997;82(1):106–112. doi:10.1210/jcem.82.1.36668989242
   PubMed Web of Science ®Google Scholar
• Langle F, Abela C, Koller-Strametz J, et al. Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg. 1994;18(4):619–624. doi:10.1007/BF03537807725754
   PubMed Web of Science ®Google Scholar
• Dalberg K, Brodin LA, Juhlin-Dannfelt A, Farnebo LO. Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg. 1996;162(3):171–176.8695729
   PubMedGoogle Scholar
• Walker MD, Fleischer JB, Di Tullio MR, et al. Cardiac structure and diastolic function in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2010;95(5):2172–2179. doi:10.1210/jc.2009-207220228165
   PubMed Web of Science ®Google Scholar
• Mishra AK, Agarwal A, Kumar S, Mishra SK. Assessment of cardiovascular system abnormalities in patients with advanced primary hyperparathyroidism by detailed echocardiographic analysis: a prospective study. World J Endoc Surg. 2017;9(2):46–50. doi:10.5005/jp-journals-10002-1209
   Google Scholar
• Harrison CV, Lennox B. Heart block in osteitis deformans. Br Heart J. 1948;10(3):167–176. doi:10.1136/hrt.10.3.16718610105
   PubMedGoogle Scholar
• King M, Huang JM, Glassman E. Paget’s disease with cardiac calcification and complete heart block. Am J Med. 1969;46(2):302–304. doi:10.1016/0002-9343(69)90014-X5775006
   PubMed Web of Science ®Google Scholar
• Strickberger SA, Schulman SP, Hutchins GM. Association of Paget’s disease of bone with calcific aortic valve disease. Am J Med. 1987;82(5):953–956. doi:10.1016/0002-9343(87)90157-43578364
   PubMed Web of Science ®Google Scholar
• Hultgren HN. Osteitis deformans (Paget’s disease) and calcific disease of the heart valves. Am J Cardiol. 1998;81(12):1461–1464. doi:10.1016/S0002-9149(98)00213-69645898
   PubMed Web of Science ®Google Scholar
• Merlotti D, Gennari L, Galli B, et al. Characteristics and familial aggregation of Paget’s disease of bone in Italy. J Bone Miner Res. 2005;20(8):1356–1364. doi:10.1359/JBMR.05032216007333
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H. Vascular calcification and osteoporosis from clinical observation towards molecular understanding. Osteoporos Int. 2007;18(3):251–259. doi:10.1007/s00198-006-0282-z17151836
   PubMed Web of Science ®Google Scholar
• Aksoy O, Cam A, Goel SS, et al. Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol. 2012;59(16):1452–1459. doi:10.1016/j.jacc.2012.01.02422497825
   PubMed Web of Science ®Google Scholar
• Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart. 2001;85(6):635–638. doi:10.1136/heart.85.6.63511359741
   PubMed Web of Science ®Google Scholar
• Bellavia D, Costa V, De Luca A, et al. Vitamin D level between calcium-phosphorus homeostasis and immune system: new perspective in osteoporosis. Curr Osteoporos Rep. 2016. doi:10.1007/s11914-016-0331-2
   Google Scholar
• Etta PK, Sharma RK, Gupta A. Study of chronic kidney disease-mineral bone disorders in newly detected advanced renal failure patients: a hospital-based cross-sectional study. Saudi J Kidney Dis Transpl. 2017;28(4):874–885.28748891
   PubMed Web of Science ®Google Scholar
• Nam HS, Shin MH, Kweon SS, et al. Association of estrogen receptor-alpha gene polymorphisms with bone mineral density in postmenopausal Korean women. J Bone Miner Metab. 2005;23(1):84–89. doi:10.1007/s00774-004-0545-8
   Web of Science ®Google Scholar
• Long JR, Zhang YY, Liu PY, et al. Association of estrogen receptor alpha and vitamin D receptor gene polymorphisms with bone mineral density in Chinese males. Calcif Tissue Int. 2004;74(3):270–276. doi:10.1007/s00223-003-0087-414595531
   PubMed Web of Science ®Google Scholar
• Nordstrom P, Glader CA, Dahlén G, et al. Oestrogen receptor alpha gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J Intern Med. 2003;254(2):140–146. doi:10.1046/j.1365-2796.2003.01179.x12859695
   PubMed Web of Science ®Google Scholar
• Bortnik AE, Bartz TM, Ix JH, et al. Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults. Heart. 2016;102(22):1826–1834. doi:10.1136/heartjnl-2016-30940427411840
   PubMed Web of Science ®Google Scholar
• Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343(25):1863–1875. doi:10.1056/NEJM20001221343250811117980
   PubMed Web of Science ®Google Scholar
• Walker MD, Rundek T, Homma S, et al. Effect of parathyroidectomy on subclinical cardiovascular disease in mild primary hyperparathyroidism. Eur J Endocrinol. 2012;167(2):277–285. doi:10.1530/EJE-12-012422660025
   PubMed Web of Science ®Google Scholar
• Schmitz F, Ewering S, Zerres K, Klomfass S, Hoffmann R, Ortlepp JR. Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis. 2009;18(3):262–267.19557980
   PubMed Web of Science ®Google Scholar